Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1:15:1466394.
doi: 10.3389/fphar.2024.1466394. eCollection 2024.

Allele frequencies and genotype distribution of three metformin transporter polymorphisms in Mexican population and their application in pharmacogenomics of type 2 diabetes

Affiliations

Allele frequencies and genotype distribution of three metformin transporter polymorphisms in Mexican population and their application in pharmacogenomics of type 2 diabetes

Oscar I Chávez-Arreola et al. Front Pharmacol. .

Abstract

Background: Metformin is the first-line antidiabetic therapy for type 2 diabetes in Mexico, despite recent recommendations highlighting alternatives like GLP-1 receptor agonists for individuals with obesity. Metformin elimination is reliant on liver and kidney function, and variants in transport proteins such as Multidrug and Toxin Extrusion Protein 1 (MATE1), MATE2, and Organic Cation Transporter 2 (OCT2) can influence its pharmacokinetics. Understanding these variants' frequencies in the Mexican population is crucial for tailoring personalized treatment strategies.

Objective: This study aimed to determine the genotypic and allelic frequencies of key variants in metformin transporters within a Mexican population, addressing the interindividual variability in drug response.

Methodology: Genetic analysis was conducted on 101 healthy, unrelated Mexican subjects who were genotyped for the MATE1, MATE2, and OCT2 variants using allele-specific real-time PCR assays.

Results: The allele frequencies were 0.07 for OCT2, 0.23 for MATE1, and 0.67 for MATE2. The g.-66T→C variant was found only in wild-type and heterozygous forms. Comparative analysis indicated significant differences in allele frequencies between this Mexican population and other ethnic groups, highlighting potential implications for metformin efficacy and safety.

Conclusion: This study provides crucial insights into the genetic variability of metformin transporter genes in a Mexican population, offering a foundation for personalized therapeutic approaches in type 2 diabetes management.

Keywords: MATE1; MATE2; Oct2; genotyping; metformin; transporters.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A) Location of SLC22A2. (B) Location of SLC47A1 y SLC47A2.

References

    1. Alexander G. C., Sehgal N. L., Moloney R. M., Stafford R. S. (2008). National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch. Intern. Med. 168, 2088–2094. 10.1001/archinte.168.19.2088 - DOI - PMC - PubMed
    1. American Diabetes Association Professional Practice Committee (2024). Introduction and methodology: Standards of Care in diabetes-2024. Diabetes Care 47, S1–S4. 10.2337/dc24-SINT - DOI - PMC - PubMed
    1. Becker M. L., Visser L. E., Van Schaik R. H. N., Hoffman A., Uitterlinden A. G., Stricker B. H. (2010). Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response. Pharmacogenet Genomics 20, 38–44. 10.1097/FPC.0b013e328333bb11 - DOI - PubMed
    1. Chen Y., Li S., Brown C., Cheatham S., Castro R. A., Leabman M. K., et al. (2009). Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin. Pharmacogenet. Genomics 19, 497–504. 10.1097/FPC.0b013e32832cc7e9 - DOI - PMC - PubMed
    1. Choi J. H., Yee S. W., Ramirez A. H., Morrissey K. M., Jang G. H., Joski P. J., et al. (2009). A common 5′-UTR variant in MATE2-K is associated with poor response to metformin. Clin. Pharmacol. Ther. 90, 674–684. 10.1038/clpt.2011.165 - DOI - PMC - PubMed

LinkOut - more resources